KSA
GSK icon

Ken Stern & Associates’s GSK GSK Stock Holding History

Ken Stern & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,022
Closed -$314K – 73
2015
Q2 		$314K Buy
6,022
+980
+19% +$55.2K 0.23% 51
2015
Q1 		$291K Buy
+5,042
New +$289K 0.22% 53

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ken Stern & Associates's GSK Position: Q3 2015 in Review

Ken Stern & Associates sold out of GSK (GSK) in Q3 2015, closing a stake of 6,022 shares — an estimated $314K sold.

Ken Stern & Associates first reported a position in GSK in Q1 2015 and held it in 2 quarters. The position peaked at $314K in Q2 2015. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Ken Stern & Associates reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Ken Stern & Associates sold 6,022 GSK shares in Q3 2015, an estimated $314K.
  • Ken Stern & Associates first reported a position in GSK in Q1 2015 and held it in 2 quarters.
  • Ken Stern & Associates's GSK position peaked at $314K in Q2 2015.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Ken Stern & Associates's 13F filing for Q3 2015, filed 17 Nov 2015.